Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 7 Sept 2026Clinical review pending
Saved on this device
!
Breathlessness with exhaustion or instability
Inability to speak, reduced consciousness, cyanosis, silent chest or haemodynamic compromise indicates threatened respiratory or circulatory failure.
Action: Call urgent resuscitation support, assess airway patency and ventilation, give indicated oxygen and treat the immediately reversible cause while preparing advanced support.
Synopsis
Assess the severity and mechanism of sudden breathlessness, treat oxygenation and ventilation failure promptly, and select focused investigations without overlooking cardiovascular or metabolic causes.
Assess speech, work of breathing, respiratory rate and conscious level before pursuing a diagnostic label.
Prescribe oxygen to a target saturation, generally 94–98% or 88–92% with hypercapnic respiratory failure risk.
A normal saturation on oxygen cannot exclude carbon-dioxide retention or respiratory fatigue.
Key red flags
New drowsiness or a falling respiratory effort during severe breathlessness can mean impending ventilatory failure and requires immediate escalation.
Investigation priorities
01
Pulse oximetry and blood gasesFirst step
Assess oxygenation, carbon-dioxide handling and acid–base disturbance.
Management branches
Immediate respiratory supportTreating the threatened airway or failing ventilation
Severe distress, hypoxaemia, fatigue or reduced consciousness makes waiting for complete investigation unsafe.
Obtain experienced help, position to support breathing when circulation allows, clear or support the airway and deliver oxygen appropriate to the immediate threat.
Assess whether spontaneous ventilation is effective; assist ventilation and prepare advanced airway support when effort or conscious level is inadequate rather than simply increasing oxygen flow.
Key medicines
Salbutamol for acute severe asthmaGive 5 mg by oxygen-driven nebuliser initially; repeat according to the acute-asthma response pathway, often every 15–30 minutes for a poor early response while senior reassessment proceeds.Monitor pulse, potassium and lactate with intensive treatment. Persistent tachypnoea may reflect worsening obstruction or beta-agonist-associated lactic acidosis and requires reassessment.
Prednisolone for an adult asthma attackGive 40–50 mg orally once daily until recovery, for a minimum of 5 days, provided the patient can swallow and absorb the medicine.Use an appropriate IV corticosteroid alternative if the oral route is unsuitable. Assess glucose and relevant infection risks; corticosteroids do not replace urgent ventilatory support.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.